Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Rethinking the use of oral agents in the treatment of type 2 diabetes mellitus
Philip Raskin
Internal Medicine
Inl Med - Endcrn Diabetes Clin
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rethinking the use of oral agents in the treatment of type 2 diabetes mellitus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Type 2 Diabetes Mellitus
69%
Hypoglycemic Agents
44%
Clinical Studies
32%
Insulin
31%
Morbidity
27%
Diabetes Complications
23%
Mortality
23%
Insulin Secretion
22%
Double-Blind Method
22%
Vascular Resistance
21%
Hyperglycemia
21%
Information Storage and Retrieval
21%
MEDLINE
20%
Publications
19%
Blood Glucose
19%
Nervous System
18%
Skeletal Muscle
18%
Language
18%
Eating
17%
Therapeutics
15%
Glucose
14%
Liver
11%
Chemical Compounds
Oral Antidiabetic Agent
100%
Insulin Derivative
94%
Glycemic
48%
Glucose
45%
Food
21%
Resistance
19%